Premium Company Profile: Neurocrine Biosciences Inc

Publication Date	November 2007
Publisher	Datamonitor
Product Type	Report
Pages	53
ISBN Number	not applicable
Product Code	DAT08679

Price

£265.00
approximately: $495 | €336

PDF

PRINT £315 ($589 | €400)

Order above formats by FAX

Summary

Neurocrine Biosciences, a neuroscience company, focuses on the discovery and development of therapeutics for the treatment of neurological and endocrine-related diseases and disorders. Neurocrine Biosciences's lead candidate Indiplon is one of the most comprehensive clinical programs for treating insomnia.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Neurocrine Biosciences is experienced in discovering and developing therapeutics for autoimmune and inflammation, cardiovascular and circulatory system, central nervous system and endocrinology. It has in-house and collaborative pipeline products and Indiplon is its lead candidate for insomnia.

The company derives its revenues from contract, licensing and collaboration. License and collaborative fees include upfront and milestone payments. During 2002-2006, the company's total revenue growth was at a CAGR of 21%. The only revenues are from licensing and collaboration

During the forecast period 2006-2010, licensing, collaboration and other revenues are forecasted to grow from $18 million to $39 million. Indiplon is expected to be the main growth driver of revenues for Neurocrine Biosciences, generating sales growth of +$83 million during the period 2006-2010.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Table Of Contents
- Overview
- Catalyst
- Summary
- Company Structure
- Company Overview And Key Facts
- Business Description
- History
- Locations And Subsidiaries
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Products & Services
- Pipeline Products
- Ac Forecast Product Sales
- Competitors And Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- Swot Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Discovery And Product Development
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- Key Employee Biographies
- Financial And Operational Overview
- Financial And Operational Overview
Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
Table Of Figures
- Figure 1: Neurocrine Biosciences - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Neurocrine Biosciences - Key Strategic Revenues, 2006-2010 ($ Mn)
Table Of Tables
- Table 1: Neurocrine Biosciences - Key Facts
- Table 2: Neurocrine Biosciences - Locations And Subsidiaries
- Table 3: Neurocrine Biosciences - Year-End Share Price And Market Capitalization, 2002-2006 ($)
- Table 4: Neurocrine Biosciences - Key Events Impacting Share Price Performance
- Table 5: Neurocrine Biosciences - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: Neurocrine Biosciences - Operating Cost Ratio Analysis, 2002-2006 (% Of Total Revenues)
- Table 7: Neurocrine Biosciences - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: Neurocrine Biosciences - Cash Flow, 2002-2006 ($ Mn)
- Table 9: Neurocrine Biosciences - In-House Pipeline Products
- Table 10: Neurocrine Biosciences - Collaborative Pipeline Products
- Table 11: Neurocrine Biosciences - Forecast Sales, 2006-2010 ($ Mn)
- Table 12: Neurocrine Biosciences - Key Competitors
- Table 13: Neurocrine Biosciences - Key Suppliers
- Table 14: Neurocrine Biosciences - Key Shareholders
- Table 15: Neurocrine Biosciences - Swot Analysis Summary
- Table 16: Neurocrine Biosciences - Value Chain Analysis
- Table 17: Neurocrine Biosciences - Scorecard
- Table 18: Neurocrine Biosciences - Key Employees
- Table 19: Neurocrine Biosciences - Financial And Operational Overview